Intuitive Surgical (ISRG) Stock Analysis & Winston Score

Intuitive Surgical makes robotic surgery systems used in hospitals around the world. Its flagship product, the da Vinci surgical robot, helps surgeons perform minimally invasive procedures — meaning smaller cuts, less pain, and faster recovery for patients. The company is the dominant player in robotic-assisted surgery and has installed its systems in thousands of hospitals globally. Intuitive makes money in a few ways: selling the da Vinci robots themselves, then charging hospitals for the instruments and accessories used in each procedure, plus annual service contracts. This "razor and blades" model means recurring revenue keeps flowing long after the initial robot sale. The company operates primarily in the US but has a growing international presence in Europe and Asia. Its large installed base and the steep learning curve surgeons face when switching systems create a strong competitive moat. The key growth driver is expanding the number of approved procedure types, while the main risk is increasing competition from newer robotic surgery entrants like Medtronic and Johnson & Johnson.